Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?
Daniel Keizman, Keren Rouvinov, Avishay Sella, Maya Gottfried, Natalie Maimon, Jenny J. Kim, Mario A. Eisenberger, Victoria Sinibaldi, Avivit Peer, Michael A. Carducci, Wilmosh Mermershtain, Raya Leibowitz-amit, Rony Weitzen, Raanan Berger
Cancer Res Treat. 2016;48(1):281-287. Published online 2015 Mar 5 DOI: https://doi.org/10.4143/crt.2014.289
Citations to this article as recorded by 
Clinical characteristics and outcomes of patients enrolled in clinical trials compared with those of patients outside clinical trials in advanced gastric cancer
Jae Joon Han, Jin Won Kim, Koung Jin Suh, Ji‐won Kim, Se Hyun Kim, Yu Jung Kim, Jee Hyun Kim, Jong Seok Lee, Keun‐Wook Lee
Asia-Pacific Journal of Clinical Oncology.2019; 15(3): 158. CrossRef
Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study
Shinji Ohno, Hirofumi Mukai, Kazutaka Narui, Yasuo Hozumi, Yasuo Miyoshi, Hiroshi Yoshino, Hiroyoshi Doihara, Akihiko Suto, Motoshi Tamura, Takashi Morimoto, Hisamitsu Zaha, Takashi Chishima, Reiki Nishimura, Takashi Ishikawa, Yukari Uemura, Yasuo Ohashi
Breast Cancer Research and Treatment.2019; 176(3): 631. CrossRef
Long-term response to sunitinib: everolimus treatment in metastatic clear cell renal cell carcinoma
Anna M Czarnecka, Paweł Sobczuk, Jan Korniluk, Marta Spychalska, Krzysztof Bogusz, Anna Owczarek, Anna Brodziak, Dominika Labochka, Barbara Moszczuk, Cezary Szczylik
Future Oncology.2017; 13(1): 31. CrossRef
Assessment of ethnic differences in sunitinib outcome between Caucasian and Asian patients with metastatic renal cell carcinoma: a meta-analysis
Xiaoyan Liu, Marta Fiocco, Jesse J. Swen, Henk-Jan Guchelaar
Acta Oncologica.2017; 56(4): 582. CrossRef
Eligibility for phase 3 clinical trials of systemic therapy in real-world patients with metastatic renal cell cancer managed in a rural region
Carsten Nieder, Mohsan A. Syed, Astrid Dalhaug, Adam Pawinski, Jan Norum
Medical Oncology.2017;[Epub] CrossRef
Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome
Agnieszka Rybarczyk, Jakub Klacz, Agata Wronska, Marcin Matuszewski, Zbigniew Kmiec, Piotr M. Wierzbicki
Oncology Reports.2017; 38(1): 427. CrossRef